SAMSARA BIOCAPITAL, LLC
PALO ALTO, CA · CIK 1744967 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2018 · limited liability company
- Assets managed$2.2bn
- Staff31 · 22 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 · $2.3bn gross assets
- Websitesamsaracap.com
- Form ADV · 2026-06-26SEC adviser record
- Kindventure
- Others nearbyPalo Alto, CA
As an employer
- Private fundsventure capital 3
US visa salary filings
- Filings FY20242
- Median salary offered$187,500
- Middle half$181,250 – $193,750
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Senior AssociatePalo Alto, CA | 2 | $187,500 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.
$488.9m
reported value
-12.8% vs Q1 2025
29positions
88.2%in top 10
3 new
1 added
8 reduced
11 sold out
vs Q1 2025
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SCHOLAR ROCK HLDG CORP SRRK | $198.8m40.66% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $76.8m15.70% | Unchanged |
| SEPTERNA INC SEPN | $33.3m6.81% | Unchanged |
| KALARIS THERAPEUTICS INC KLRS | $30.6m6.25% | Unchanged |
| NEUROGENE INC NGNE | $25.7m5.25% | Unchanged |
| CARGO THERAPEUTICS INC COM | $18.2m3.72% | Unchanged |
| UPSTREAM BIO INC UPB | $15.8m3.24% | Reduced -623.9k |
| ALUMIS INC ALMS | $14.4m2.95% | Added +1.5m |
| LENZ THERAPEUTICS INC LENZ | $10.1m2.06% | Reduced -183.4k |
| PALVELLA THERAPEUTICS INC NE PVLA | $7.7m1.57% | Reduced -339.7k |
| GOSSAMER BIO INC GOSS | $7.5m1.54% | Unchanged |
| ARCELLX INC ACLX | $6.7m1.37% | Reduced -33.8k |
| AURA BIOSCIENCES INC AURA | $6.3m1.28% | New |
| NKARTA INC NKTX | $6.3m1.28% | Unchanged |
| AVADEL PHARMACEUTICALS PLC AVDL | $6.0m1.22% | Reduced -292.0k |
| JADE BIOSCIENCES INC JBIO | $5.3m1.09% | New |
| ZYMEWORKS INC ZYME | $3.9m0.80% | Reduced -356.4k |
| RHYTHM PHARMACEUTICALS INC RYTM | $3.2m0.65% | Reduced -87.6k |
| VTV THERAPEUTICS INC VTVT | $3.1m0.63% | Unchanged |
| CONTINEUM THERAPEUTICS INC CTNM | $2.3m0.48% | Unchanged |
| SURROZEN INC SRZN | $2.2m0.44% | Unchanged |
| SUTRO BIOPHARMA INC COM | $1.6m0.32% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $1.1m0.22% | Reduced -420.0k |
| HILLEVAX INC COM | $795.3k0.16% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $754.8k0.15% | Unchanged |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $440.4k0.09% | Unchanged |
| BOLT BIOTHERAPEUTICS INC BOLT | $302.7k0.06% | New |
| NUVATION BIO INC NUVB.WS | $36.0k0.01% | Unchanged |
| SURROZEN INC *W EXP 08/01/203 | $1.8k0.00% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| ACELYRIN INC | $6.2m2.5m shares |
| ONKURE THERAPEUTICS INC OKUR | $3.5m824.2k shares |
| ABIVAX SA ABVX | $2.7m425.0k shares |
| INOZYME PHARMA INC | $1.4m1.6m shares |
| PRIME MEDICINE INC PRME | $806.4k405.2k shares |
| LEAP THERAPEUTICS INC CYPH | $745.2k2.4m shares |
| BOLT BIOTHERAPEUTICS INC | $419.7k1.0m shares |
| CURIS INC | $390.5k185.9k shares |
| LYRA THERAPEUTICS INC LYRA | $175.6k1.4m shares |
| KRONOS BIO INC KRON | $64.5k78.1k shares |
| ALLAKOS INC ALLKG | $39.2k172.1k shares |